LFTSF vs ABT: Which Stock is Better?

Side-by-side comparison of LifeTech Scientific Corporation and Abbott Laboratories in 2026

Comparison Updated:

LFTSF

LifeTech Scientific Corporation

$0.23

ABT

Abbott Laboratories

$96.81

Key Metrics Comparison

MetricLFTSFABTWinner
Market Cap$1.03B$168.23BABT
P/E Ratio23.3526.74LFTSF
EPS (TTM)$0.01$3.62ABT
Revenue Growth0.1%0.1%ABT
Gross Margin74.4%56.5%LFTSF

Analyze LFTSF

Full quant analysis

Analyze ABT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LFTSF or ABT a better investment?

Comparing LFTSF and ABT: LifeTech Scientific Corporation has a market cap of $1.03B while Abbott Laboratories has $168.23B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LFTSF and ABT?

LFTSF (LifeTech Scientific Corporation) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LFTSF or ABT?

Based on P/E ratios, LFTSF trades at a lower multiple (23.4x vs 26.7x).

Which is growing faster: LFTSF or ABT?

ABT has higher revenue growth at 0.1% vs 0.1% for LFTSF.

Which company is more profitable: LFTSF or ABT?

LifeTech Scientific Corporation (LFTSF) has higher gross margins at 74.4% compared to 56.5% for ABT.

Which is the larger company: LFTSF or ABT?

Abbott Laboratories (ABT) is larger with a market cap of $168.23B compared to $1.03B for LFTSF.

Should I buy LFTSF or ABT in 2026?

Both LFTSF and ABT have investment merit. LFTSF trades at $0.23 while ABT trades at $96.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LFTSF and ABT stock?

Key differences: Market Cap ($1.03B vs $168.23B), P/E Ratio (23.4x vs 26.7x), Revenue Growth (0.1% vs 0.1%), Gross Margin (74.4% vs 56.5%).

Popular Stock Comparisons